Molecular BiologyJCI InsightPeer-reviewed
Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva
Eleanor Williams, Jana Bagarova, Georgina Kerr…·Alex N. Bullock
The paper identifies saracatinib as a potent ALK2 inhibitor effective in preventing heterotopic ossification in FOP models.
73 citationstop 1%